How to prepare a patient with pheochromocytoma for surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Preoperative Management of Pheochromocytoma for Surgery

All patients with pheochromocytoma should receive preoperative alpha-adrenergic blockade for at least 10-14 days before surgery to prevent hypertensive crises and arrhythmias during the procedure. 1

Alpha-Adrenergic Blockade Protocol

  • Begin alpha-adrenergic blockade 10-14 days before surgery with specific blood pressure targets of <130/80 mmHg in the supine position and systolic blood pressure >90 mmHg in the upright position 1, 2
  • Two main options for alpha blockade:
    • Non-selective, non-competitive alpha-blocker: Phenoxybenzamine (FDA-approved for pheochromocytoma) 3
      • Starting dose: 10 mg twice daily with adjustments every 2-4 days 1
    • Selective alpha-1 blockers: Doxazosin, prazosin, or terazosin 1, 2
      • May have fewer side effects than phenoxybenzamine 1
      • Phenoxybenzamine may provide less intraoperative hemodynamic instability compared to selective blockers 1, 2

Additional Preoperative Medications

  • Beta-blockers should ONLY be added after adequate alpha blockade if tachyarrhythmias develop 1, 2, 3
    • Never start beta-blockers before alpha-blockers as this can precipitate a hypertensive crisis 1, 2
  • If target blood pressure is not achieved with alpha blockade alone, consider:
    • Calcium channel blockers (nifedipine slow release) 1, 2
    • Metyrosine (alpha-methyl-p-tyrosine) - inhibits catecholamine synthesis 1, 4, 5
      • Studies suggest the combination of metyrosine with alpha-blockers results in better blood pressure control, less blood loss, and reduced need for intraoperative medications 4, 5

Volume Expansion

  • High-sodium diet and administration of 1-2 liters of saline 24 hours before surgery 2
  • Use compressive stockings to reduce the risk of orthostatic and postoperative hypotension 2
  • Adequate volume expansion is crucial to prevent postoperative hypotension 1

Intraoperative Management

  • Be prepared to manage hypertensive episodes with:
    • Magnesium sulfate 1
    • Intravenous alpha-adrenergic antagonist (phentolamine) 1
    • Calcium channel blockers 1
    • Nitroprusside or nitroglycerin 1, 2
  • For tachycardia, use intravenous beta-blockers such as esmolol 1, 2
  • Monitor for hypotension after tumor removal, which should be treated aggressively with fluid resuscitation 1, 2

Postoperative Care

  • Monitor glucose levels carefully as hypoglycemia may occur after reduction of catecholamine levels 1, 2
  • Continue hemodynamic monitoring for 24-48 hours postoperatively 6
  • Biochemical testing should be performed 2-8 weeks after surgery to confirm complete resection 2, 7

Common Pitfalls to Avoid

  • Never starting beta-blockers before adequate alpha blockade 1, 2, 8
  • Inadequate duration of preoperative alpha blockade (should be at least 10-14 days) 1
  • Insufficient volume expansion, leading to postoperative hypotension 1, 2
  • Failure to monitor for hypoglycemia after tumor removal 1, 2

Special Considerations

  • For bilateral pheochromocytomas, functional tumors should be resected as an initial priority 2
  • In patients with hereditary syndromes, consider cortical-sparing techniques versus total adrenalectomy 2
  • Laparoscopic approach is preferred for most pheochromocytomas, but open surgery should be considered for tumors >6 cm or with suspicion of malignancy 2

This protocol optimizes preoperative management to minimize perioperative morbidity and mortality in patients undergoing surgery for pheochromocytoma.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Operative Management of Bilateral Pheochromocytoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Metyrosine and pheochromocytoma.

Archives of internal medicine, 1997

Guideline

Pheochromocytoma Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Case report: pheochromocytoma. Aspects of management.

Anaesthesia and intensive care, 1976

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.